@article{ART001565871},
author={Ilhak LEE and Koo， Young-Mo},
title={Ethical Principles in Physician-Pharmaceutical Industry Interactions},
journal={Korean Journal of Medical Ethics },
issn={2005-8284},
year={2011},
volume={14},
number={2},
pages={193-201},
doi={10.35301/ksme.2011.14.2.193}
TY - JOUR
AU - Ilhak LEE
AU - Koo， Young-Mo
TI - Ethical Principles in Physician-Pharmaceutical Industry Interactions
JO - Korean Journal of Medical Ethics
PY - 2011
VL - 14
IS - 2
PB - The Korean Society For Medical Ethics
SP - 193
EP - 201
SN - 2005-8284
AB - This article examines the four principles of biomedical ethics introduced by Beauchamp and Childress for possible use in deliberating ethical issues that arise in the context of physician-pharmaceutical industry interactions (PPII). PPII is regarded as a threat to the ideal physician-patient relationship because it blurs the scientific, objective, and altruistic ideals of professional medical practice. Several guidelines have been proposed to redress the undesirable effects of PPII, but few have provided any ethical justification or mechanism to resolve possible internal conflicts. The principle-based approach is a good starting point because it focuses on practical solutions for decision-making as well as on theoretical justifications. This article shows how the four ethical principles can be specified and applied in three hypothetical cases of PPII, and how two practical rules, the rule of transparency and avoidance, can be assimilated.
KW - ethical principles;physician-pharmaceutical industry interaction;specification ethics;medical ethics
DO - 10.35301/ksme.2011.14.2.193
ER -
Ilhak LEE and Koo， Young-Mo. (2011). Ethical Principles in Physician-Pharmaceutical Industry Interactions. Korean Journal of Medical Ethics , 14(2), 193-201.
Ilhak LEE and Koo， Young-Mo. 2011, "Ethical Principles in Physician-Pharmaceutical Industry Interactions", Korean Journal of Medical Ethics , vol.14, no.2 pp.193-201. Available from: doi:10.35301/ksme.2011.14.2.193
Ilhak LEE, Koo， Young-Mo "Ethical Principles in Physician-Pharmaceutical Industry Interactions" Korean Journal of Medical Ethics 14.2 pp.193-201 (2011) : 193.
Ilhak LEE, Koo， Young-Mo. Ethical Principles in Physician-Pharmaceutical Industry Interactions. 2011; 14(2), 193-201. Available from: doi:10.35301/ksme.2011.14.2.193
Ilhak LEE and Koo， Young-Mo. "Ethical Principles in Physician-Pharmaceutical Industry Interactions" Korean Journal of Medical Ethics 14, no.2 (2011) : 193-201.doi: 10.35301/ksme.2011.14.2.193
Ilhak LEE; Koo， Young-Mo. Ethical Principles in Physician-Pharmaceutical Industry Interactions. Korean Journal of Medical Ethics , 14(2), 193-201. doi: 10.35301/ksme.2011.14.2.193
Ilhak LEE; Koo， Young-Mo. Ethical Principles in Physician-Pharmaceutical Industry Interactions. Korean Journal of Medical Ethics . 2011; 14(2) 193-201. doi: 10.35301/ksme.2011.14.2.193
Ilhak LEE, Koo， Young-Mo. Ethical Principles in Physician-Pharmaceutical Industry Interactions. 2011; 14(2), 193-201. Available from: doi:10.35301/ksme.2011.14.2.193
Ilhak LEE and Koo， Young-Mo. "Ethical Principles in Physician-Pharmaceutical Industry Interactions" Korean Journal of Medical Ethics 14, no.2 (2011) : 193-201.doi: 10.35301/ksme.2011.14.2.193
1,
Koo， Young-Mo
2
